Zobrazit minimální záznam

Longitudinal progression of choroid plexus enlargement is associated with female sex, cognitive decline and ApoE E4 homozygote status

dc.contributor.authorNováková Martínková, Julie
dc.contributor.authorFerretti, Maria Teresa
dc.contributor.authorFerrari, Alberto
dc.contributor.authorLerch, Ondřej
dc.contributor.authorMatušková, Veronika
dc.contributor.authorSečník, Juraj
dc.contributor.authorHort, Jakub
dc.date.accessioned2024-01-15T11:10:36Z
dc.date.available2024-01-15T11:10:36Z
dc.date.issued2023
dc.identifier.urihttps://hdl.handle.net/20.500.14178/2188
dc.description.abstractINTRODUCTION: Choroid plexus (CP)-related mechanisms have been implicated in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease. In this pilot study, we aimed to elucidate the association between longitudinal changes in CP volume, sex and cognitive impairment. METHODS: We assessed longitudinal changes in CP volume in a cohort of n = 613 subjects across n = 2,334 datapoints from ADNI 2 and ADNI-GO, belonging to cognitively unimpaired (CN), stable mild cognitive impairment (MCI), clinically diagnosed Alzheimer's disease dementia (AD) or convertor (to either AD or MCI) subgroups. CP volume was automatically segmented and used as a response variable in linear mixed effect models with random intercept clustered by patient identity. Temporal effects of select variables were assessed by interactions and subgroup analyses. RESULTS: We found an overall significant increase of CP volume in time (14.92 mm(3) per year, 95% confidence interval, CI (11.05, 18.77), p < 0.001). Sex-disaggregated results showed an annual rate of increase 9.48 mm(3) in males [95% CI (4.08, 14.87), p < 0.001], and 20.43 mm(3) in females [95% CI (14.91, 25.93), p < 0.001], indicating more than double the rate of increase in females, which appeared independent of other temporal variables. The only diagnostic group with a significant CP increase as compared to CN was the convertors group, with an increase of 24.88 mm(3)/year [95% CI (14, 35.82), p < 0.001]. ApoE exhibited a significant temporal effect, with the E4 homozygote group's CP increasing at more than triple the rate of non-carrier or heterozygote groups [40.72, 95% CI (25.97, 55.46), p < 0.001 vs. 12.52, 95% CI (8.02, 17.02), p < 0.001 for ApoE E4 homozygotes and E4 non-carriers, respectively], and may have modified the diagnostic group relationship. CONCLUSION: Our results contribute to potential mechanisms for sex differences in cognitive impairment with a novel finding of twice the annual choroid plexus enlargement in females and provide putative support for CP-related mechanisms of cognitive deterioration and its relationship to ApoE E4.en
dc.language.isoen
dc.relation.urlhttps://doi.org/10.3389/fpsyt.2023.1039239
dc.rightsCreative Commons Uveďte původ 4.0 Internationalcs
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.titleLongitudinal progression of choroid plexus enlargement is associated with female sex, cognitive decline and ApoE E4 homozygote statusen
dcterms.accessRightsembargoedAccess
dcterms.licensehttps://creativecommons.org/licenses/by/4.0/legalcode
dc.date.updated2024-01-15T11:10:36Z
dc.subject.keywordAlzheimer’s diseaseen
dc.subject.keywordchoroid plexusen
dc.subject.keywordcognitive impairmenten
dc.subject.keywordlongitudinal analysisen
dc.subject.keywordsex differencesen
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/GAUK/GAUK436119
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM//LX22NPO5107
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/FN/I-FN/I-FNM
dc.date.embargoStartDate2024-01-15
dc.date.embargoEndDate2023-03-08
dc.type.obd73
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doi10.3389/fpsyt.2023.1039239
dc.identifier.utWos000954312800001
dc.identifier.eidScopus2-s2.0-85150499933
dc.identifier.obd625975
dc.identifier.pubmed36970283
dc.subject.rivPrimary30000::30100::30103
dcterms.isPartOf.nameFrontiers in Psychiatry [online]
dcterms.isPartOf.issn1664-0640
dcterms.isPartOf.journalYear2023
dcterms.isPartOf.journalVolume14
dcterms.isPartOf.journalIssueMarch
uk.faculty.primaryId109
uk.faculty.primaryName2. lékařská fakultacs
uk.faculty.primaryNameSecond Faculty of Medicineen
uk.faculty.secondaryId52
uk.faculty.secondaryNameFakultní nemocnice v Motolecs
uk.faculty.secondaryNameMotol University Hospitalen
uk.department.primaryId109
uk.department.primaryName2. lékařská fakultacs
uk.department.primaryNameSecond Faculty of Medicineen
uk.department.secondaryId100010692569
uk.department.secondaryId1682
uk.department.secondaryNameNeurologická klinika 2. LF UK a FN Motolcs
uk.department.secondaryNameDepartment of Neurology, 2nd Faculty of Medicine and Motol University Hospitalen
uk.department.secondaryNameNeurologická klinikacs
uk.department.secondaryNameDepartment of Neurologyen
dc.type.obdHierarchyCsČLÁNEK V ČASOPISU::článek v časopisu::původní článekcs
dc.type.obdHierarchyEnJOURNAL ARTICLE::journal article::original articleen
dc.type.obdHierarchyCode73::152::206en
uk.displayTitleLongitudinal progression of choroid plexus enlargement is associated with female sex, cognitive decline and ApoE E4 homozygote statusen


Soubory tohoto záznamu

Thumbnail

Tento záznam se objevuje v následujících kolekcích

Zobrazit minimální záznam